1. Home
  2. CETX vs BOLT Comparison

CETX vs BOLT Comparison

Compare CETX & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$1.13

Market Cap

12.3M

Sector

Technology

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

N/A

Current Price

$4.78

Market Cap

10.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CETX
BOLT
Founded
1998
2015
Country
United States
United States
Employees
244
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
10.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CETX
BOLT
Price
$1.13
$4.78
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$34.00
AVG Volume (30 Days)
6.2M
24.9K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,695,000.00
Revenue This Year
$20.41
N/A
Revenue Next Year
N/A
$133.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.07
52 Week Low
$0.37
$0.26
52 Week High
$9.70
$7.35

Technical Indicators

Market Signals
Indicator
CETX
BOLT
Relative Strength Index (RSI) 52.98 50.52
Support Level $0.56 $4.27
Resistance Level $1.41 $5.22
Average True Range (ATR) 0.10 0.44
MACD -0.01 -0.01
Stochastic Oscillator 19.70 24.19

Price Performance

Historical Comparison
CETX
BOLT

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded into a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. The company's operating segment includes the Security segment and the Industrial Services segment. The security segment provides end-to-end security to all industrial, corporate, and governmental security via its owned subsidiary, Vicon. Whereas the AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in-plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment, and from the USA. It also operates UK, USA, and Other.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: